Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Guihuan Qiu
Observed names:
G. Qiu,
G.P. Qiu,
Gui-Huan Qiu
Institutions:
First Affiliated Hospital of Guangzhou Medical University,
State Key Laboratory of Respiratory Disease,
Guangzhou Institute of Respiratory Health
Observed institutions:
First Affiliated Hospital of Guangzhou Medical University,
State Key Laboratory of Respiratory Disease,
Guangzhou Institute of Respiratory Health,
Guangzhou Medical University
ORCID:
0000-0003-0281-676X
Observed ORCID:
0000-0003-0281-676X
OpenAlex ID:
A5018911856
Peripheral Blood Biomarkers for Early Diagnosis, Severity, and Prognosis of Checkpoint Inhibitor-Related Pneumonitis in Patients With Lung Cancer
2021
·
Xinqing Lin
, Haiyi Deng
, et al.
·
Frontiers in Oncology
·
95
PDF
Safety and efficacy of immunotherapy rechallenge following checkpoint inhibitor-related pneumonitis in advanced lung cancer patients: a retrospective multi-center cohort study
2022
·
Xinqing Lin
, Haiyi Deng
, et al.
·
Translational Lung Cancer Research
·
34
PDF
Clinical impact of first‐line PD ‐1 or PD‐L1 inhibitors combined with chemotherapy in extensive‐stage small cell lung cancer patients: A real‐world multicenter propensity score‐matched study
2023
·
Jingyuan Xie
, Mo Chen
, et al.
·
Thoracic Cancer
·
33
Induction chemotherapy followed by camrelizumab plus apatinib and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, single-arm trial
2025
·
Ming Liu
, Guihuan Qiu
, et al.
·
Signal Transduction and Targeted Therapy
·
26
PDF
A retrospective real‐world experience of immunotherapy in patients with extensive stage small‐cell lung cancer
2023
·
Guihuan Qiu
, Fei Wang
, et al.
·
Cancer Medicine
·
25
PDF
Proposed clinical phases for the improvement of personalized treatment of checkpoint inhibitor–related pneumonitis
2022
·
Chengzhi Zhou
, Yilin Yang
, et al.
·
Frontiers in Immunology
·
19
PDF
A Risk-Scoring Model for Severe Checkpoint Inhibitor-Related Pneumonitis: A Case–Control Study
2023
·
Haiyi Deng
, Jiating Deng
, et al.
·
Clinical Drug Investigation
·
17
Identification and validation of a ferroptosis-related prognostic risk-scoring model and key genes in small cell lung cancer
2022
·
Suyang Li
, Guihuan Qiu
, et al.
·
Translational Lung Cancer Research
·
12
PDF
Combined small cell lung cancer: current progress and unmet needs.
2023
·
Chen Zeng
, Guihuan Qiu
, et al.
·
PubMed Central
·
11
PDF
Immune thrombocytopenia in a small cell lung cancer patient treated with atezolizumab: a case report
2022
·
Guihuan Qiu
, Suyang Li
, et al.
·
Translational Lung Cancer Research
·
10
PDF
Sintilimab with chemotherapy as first-line treatment for locally advanced or metastatic squamous non-small-cell lung cancer: a real-world data study
2022
·
Xinqing Lin
, Haiyi Deng
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
9
PDF
Case Report: A Rare Case of Metachronous Multiple Primary Lung Cancers in a Patient With Successful Management by Switching From Anti-PD-1 Therapy to Anti-PD-L1 Therapy
2021
·
Xinqing Lin
, Guihuan Qiu
, et al.
·
Frontiers in Immunology
·
9
PDF
A case report and literature review on respiratory failure with immune checkpoint inhibitors: a life-threatening adverse event
2023
·
Xinqing Lin
, Wenhui Guan
, et al.
·
Immunopharmacology and Immunotoxicology
·
8
Recurrent pleural effusion as a rare manifestation after prolonged PD1 inhibitor (camrelizumab)-based immunotherapy: A case report
2023
·
Xiao-Hong Xie
, Pan-Xiao Shen
, et al.
·
Human Vaccines & Immunotherapeutics
·
6
PDF
Characteristics and prognosis of EGFR mutations in small cell lung cancer patients in the NGS era
2023
·
Xiaohong Xie
, Guihuan Qiu
, et al.
·
Clinical & Translational Oncology
·
6
PDF
Biological and clinical characteristics of non-small cell lung cancer non-specific subtype
2024
·
Xiaohong Xie
, Chen Zeng
, et al.
·
Heliyon
·
3
A multicenter phase I/II trial of induction chemotherapy followed by camrelizumab, apatinib, plus chemotherapy as first-line treatment for extensive-stage small-cell lung cancer.
2023
·
Chengzhi Zhou
, Ming Liu
, et al.
·
Journal of Clinical Oncology
·
1
P1.01-131 The Comparison Between Non-Intubated and Intubated Anesthesia Video-Assisted Thoracoscopic Surgery: A Meta-Analysis
2019
·
G. Qiu
·
Journal of Thoracic Oncology
·
1
Phase I Clinical Trial of Autologous Hematopoietic Stem Cell Transplantation-Supported Dose-Intensified Chemotherapy With Adebrelimab as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
2024
·
Ming Liu
, Wenhui Guan
, et al.
·
Clinical Lung Cancer
P2.09-04 The Clinicopathological Characteristics and Prognosis of Lung Cancer with Tumor Spread Through Air Spaces: A Meta-Analysis
2019
·
Y. Wen
, G. Qiu
, et al.
·
Journal of Thoracic Oncology
Optimal starting age for lung cancer screening with low-dose CT: A population level analysis
2018
·
C.C.C. Li
, H.R. Liang
, et al.
·
Annals of Oncology
PDF
P3.16-46 The Comparison Between Non-Intubated and Intubated Thoracoscopic Resection for Pulmonary Nodule: A Meta-Analysis
2018
·
Y. Wen
, G. Qiu
, et al.
·
Journal of Thoracic Oncology
P1.16-41 The Role of Surgery in Pulmonary Large Cell Neuroendocrine Carcinoma: A Propensity-Score Matching Analysis of SEER Database
2018
·
Z. Liu
, H. Liang
, et al.
·
Journal of Thoracic Oncology
Show more works
View as search
Works count:
23
Citation count:
325
H-index:
10
I10-index:
10
Year
Topic
Type